Enzyme Stabilizer Market Focusing on Product Innovation and Advanced Features
Posted by Arslan on July 1st, 2019
As per the current market trends and the promising nature of the enzyme stabilizer market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, FACTMR would be publishing a resourceful analysis that will enclose knowledge about the regional enzyme stabilizer market size, revenue and opportunity status. Readers will be offered the privilege to decode various facets of the market during 2018-2027, together with the active access to secondary and primary research methodology. Furthermore, various segments of the market associated to product, application, end-user etc., would also be present in this intelligent research report.
To Get a Free Sample Copy of this Report, Visit here – https://www.factmr.com/connectus/sample?flag=S&rep_id=2660
Notable Developments in Enzyme Stabilizer Market
- AIMMS (Amsterdam Institute for Molecules, Medicines, and Systems) researchers have developed a new way of stabilizing enzymes to enhance their tolerance towards chemical and thermal stress. The researchers enforced enzyme integrity with tiny molecular clamps, which were linked to the enzyme’s surface. These clamps helped protect the enzyme from disintegration under environmental stress, such as elevated temperatures. The technology can help improve enzyme robustness for specific applications.
- Galafold® (migalastat) by Amicus Therapeutics, a global biotechnology company, received the 2018 UK Prix Galien Medal for Innovative Product. This award is given to companies making notable advances in pharmaceutical research. Galafold® capsules 123 mg (migalastat) is a novel therapy designed for chaperone, which also gained approval in Japan to be used as a Fabry disease monotherapy in individuals with amenable mutations.
- Researchers have created a novel genetic engineering technique to significantly enhance an enzyme’s ability to breakdown biomass. Referred to as Evolution by Amplification and Synthetic Biology (EASy), the new method helped the researchers in accelerating the evolution of the desirable traits of a microorganism. Sigma Aldrich (Merck), a prominent player in the enzyme stabilizer market, has recently launched an enzyme stabilizer called BioStab enzyme stabilizer, which can protect antibodies from degradation effects. The enzyme stabilizer is effective in increasing the lifetime and coating rates of the antibodies.
- Archer Daniels Midland Company (ADM), a leading player in enzyme stabilizer market, has opened a new enzyme lab in Davis, California. The scientists at this lab will work along with ADM’s other R&D facilities across the globe to develop enzyme products to cater to a wide range of markets. Also, ADM and Qingdao Vland Biotech Group Co., Ltd., have collaborated to create and commercialize feed enzymes to enhance animal nutrition and health.
- BASF Animal Nutrition has unveiled its Lucantin® NXT product line in the EU 28 market. Its latest carotenoids are stabilized by tocopherol or propyl gallate (PG) and butylhydroxytoluene (BHT). Lucantin® NXT formulations have replaced ethoxyquin (EQ) as stabilizer. The latest formulations are showing remarkable performance with high homogeneity, long shelf life and exceptional stability.
The report on enzyme stabilizer market also provides comprehensive analysis on the key players in the enzyme stabilizer market. The report profiles some of the key players functioning in the enzyme stabilizer market, including Cargill Inc., Roche CustomBiotech, Ab Vickers, UK, Archer Daniels Midland, USA, Sorachim SA, Sigma Aldrich (Merck), Bitop, Biomol, Sun Chemical, and Bio World.
Tier 1 companies, including Cargill Inc., Archer Daniels Midland, and Roche Diagnostics International Limited account for nearly 50-55% market share. This indicates a high consolidation of the enzyme stabilizer market at the top. The tier 2 and tier 3 market players account for 25-30% and 15-25% market share respectively. The prominent market players in enzyme stabilizer market are focusing on maintaining their hegemony. Expansion of production capacities and vertical integration for business development are among the key strategies of Tier 1 players.
